Aureka Biotechnologies announced the completion of a US$100 million Series B financing round on August 10, 2026. Granite Asia provided the first tranche as the sole investor, while a leading …
Kaigene, Inc., a U.S. biotechnology company focused on developing next-generation antibody therapies for autoimmune diseases, has announced an exclusive licensing partnership with Taisho Pharmaceutical Co., Ltd., one of Japan’s leading …
AsymBio, the biologics-focused Contract Development and Manufacturing Organization (CDMO) under the Asymchem Group (stock codes: 002821.SZ / 6821.HK), has announced the groundbreaking of a new research and development facility at …
Arcera Life Sciences a global life sciences firm based in Abu Dhabi, and Shanghai Fosun Pharmaceutical Group Co Ltd, an innovation-led international pharmaceutical and healthcare company, have announced the signing …
Harbour BioMed, a global biopharmaceutical company focused on advancing innovative antibody-based therapies in immunology and immune-oncology, has announced the online publication of results from the first-in-human Phase I clinical trial …
Advancing Access to Healthcare through Innovation and Partnerships Expanding access to medicines and healthcare relies on the continuous creation of evidence-driven solutions to address unmet medical needs. To support this …
